Myelin-oligodendrocyte glycoprotein antibody-associated disease (MOGAD) is a recently
identified autoimmune disorder that presents in both adults and children as CNS demyelination…

Over the past few years, increasing interest in the role of autoantibodies against myelin
oligodendrocyte glycoprotein (MOG-abs) as a new candidate biomarker in demyelinating central …

… Kumaran Deiva has received speaker/consultant honoraria from Novartis and Biogen,
but has no COI with this manuscript. Rinze F. Neuteboom participates in trials by Sanofi and …

Importance Myelin oligodendrocyte glycoprotein antibodies (MOG-Abs) are consistently
identified in a range of demyelinating disorders in adults and children. Current therapeutic …

… K. Deiva received funds from Merck Serono and travel subsidies and speaker fees from …
K. Riney has received support from Novartis to attend a meeting and an honorarium for …

Importance Overall, immunotherapy has been shown to improve outcomes and reduce
relapses in individuals withN-methyl-d-aspartate receptor (NMDAR) antibody encephalitis (…

… None of the patients could be tested by the WPPSI-III, K-ABC, or Conners tests, because
of their level of disability. Evaluations were performed by the same trained neuropsychologist …

Herpes simplex virus encephalitis (HSVE) is a devastating condition that relapses, often
with a chorea in children, despite adequate antiviral treatment. At relapse, evidence of viral …

Objective To create an international consensus treatment recommendation for pediatric
NMDA receptor antibody encephalitis (NMDARE). Methods After selection of a panel of 27 …

… K. Deiva has received travel funding from Biogen and Merck Serono. C. Hemingway has
received speaker honoraria from Biogen Idec, Terumo Products, Merck Serono, and Bayer and …